Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Danavox is a global provider of hearing care solutions, specializing in the development and manufacture of advanced hearing aids and audiological accessories. Originally founded in 1943 in Denmark, the company became a pioneer in the hearing aid industry before being integrated into the GN Group. Today, Danavox operates as a key brand within the GN Hearing division, offering a comprehensive portfolio of digital hearing instruments designed to improve the quality of life for individuals with hearing impairment. Their product range includes behind-the-ear and custom in-the-ear devices that leverage sophisticated sound processing technology to enhance speech clarity and user comfort.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Danavox.